| [1] |
张胜雷,田芮聪,靳晶晶,等. IgA肾病患者的淋巴细及肾脏预后的关系胞亚群与临床病理特征[J]. 实用医学杂志,2025,41(3):352-357.
|
| [2] |
LIU S D, LU Z Z, FU Z K, et al. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study[J]. Kidney Blood Press Res,2023,48(1): 186-193. doi:10.1159/000529822
doi: 10.1159/000529822
|
| [3] |
PEI G Q, QIN A Y, DONG L Q,et al. Prognostic value of triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) in IgA nephropathy patients[J].Front Endocrinol (Lausanne),2022,13:877794. doi:10.3389/fendo.2022.877794
doi: 10.3389/fendo.2022.877794
|
| [4] |
ZHUANG H J, LIN Z L, ZENG S H,et al.Dyslipidemia may be a risk factor for progression in children with IgA nephropathy[J].Pediatr Nephrol,2022,37 (12):3147-3156. doi:10.1007/s00467-022-05480-x
doi: 10.1007/s00467-022-05480-x
|
| [5] |
ANGELA P, ALBERICO L C. Remnant cholesterol: A reliable prognostic marker?[J]. Eur J Prev Cardiol,2024,31(10): 1203-1204. doi:10.1093/eurjpc/zwad107
doi: 10.1093/eurjpc/zwad107
|
| [6] |
DENG J H, TANG R Y, CHEN J X,et al. Remnant cholesterol as a risk factor for all-cause and cardiovascular mortality in incident peritoneal dialysis patients[J]. Nutr Metab Cardiovasc Dis,2023,33(5):1049-1056. doi:10.1016/j.numecd.2023.02.009
doi: 10.1016/j.numecd.2023.02.009
|
| [7] |
LI B, WANG A, WANG Y,et al. A study on the correlation between remnant cholesterol and urinary albumin to creatinine ratio in Chinese community adults: A report from the REACTION study[J]. J Diabetes,2020, 12(2):870-880. doi:10.1111/1753-0407.13076
doi: 10.1111/1753-0407.13076
|
| [8] |
SOO Y J, MIN W K, EYUN S,et al. Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: A nationwide population-based study[J]. Diabetes Research and Clinical Practice,2024,210:111639. doi:10.1016/j.diabres.2024.111639
doi: 10.1016/j.diabres.2024.111639
|
| [9] |
ZHU W, LIU Q, LIU F,et al. High remnant cholesterol as a risk factor for developing chronic kidney disease in patients with prediabetes and type 2 diabetes: A cross-sectional study of a US population[J]. Acta Diabetol,2024,61(6):735-743. doi:10.1007/s00592-024-02249-6
doi: 10.1007/s00592-024-02249-6
|
| [10] |
TRIMARCHI H, BARRATT J, CATTRAN D C, et al. Oxford classification of IgA nephropathy 2016:An update from the IgA nephropathy classification working group[J]. Kidney Int,2017,91(5):1014-1021.
|
| [11] |
XIONG Y J, SHAO D M, ZHU X Y,et al. Joint Association of Remnant Cholesterol and Body Mass Index with Hypertension: A National Cohort Study in Chinese Adults[J]. J Multidiscip Healthc,2025,30(18):1813-1825.
|
| [12] |
PASCHALIS K, DIMITRIOS P, MANFREDI R,et al. Association between remnant cholesterol and chronic kidney disease: Systematic review and meta-analysis[J]. Diabe tes Obes Metab,2025,27(5):2573-2583.
|
| [13] |
YUAN Y G, HU X M, ZHANG S H,et al. High remnant-cholesterol levels increase the risk for end-stage renal disease: A nationwide, population-based,cohort study[J]. J Multidiscip Healthc,2025,30 (18):1813-1825.
|
| [14] |
DUCASA G M, MITROFANOVA A, MALLELA S K, et al. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes[J]. J Clin Invest,2019,129(8):3387-3400. doi:10.1172/jci125316
doi: 10.1172/jci125316
|
| [15] |
ZHAO Y F, ZHU L, LIU L J, et al. Measures of urinary protein and albumin in the prediction of progression of IgA nephropathy[J]. Clin J Am Soc Nephrol,2016,11(6):947-955. doi:10.2215/cjn.10150915
doi: 10.2215/cjn.10150915
|
| [16] |
WANG S Q, DONG L Q, QIN A Y, et al. Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN[J]. Int Immunopharmacol,2023,120:110354. doi:10.1016/j.intimp.2023.110354
doi: 10.1016/j.intimp.2023.110354
|
| [17] |
HONG Y A, MIN J W, MYUNGy A H, et al. The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy[J]. J Clin Med,2020,9(9):2824. doi:10.3390/jcm9092824
doi: 10.3390/jcm9092824
|
| [18] |
NORDESTGAAR D B G.Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease:New insights from epidemiology,genetics,and biology[J]. Circ Res,2016,118(4):547-563. doi:10.1161/circresaha.115.306249
doi: 10.1161/circresaha.115.306249
|
| [19] |
MA L, GILANI A, RUBIO-NAVARRO A, et al. Adipsin and adipocyte-derived C3aR1 regulate thermogenic fat in a sex-dependent fashion[J]. JCI Insight,2024,9(11):e178925. doi:10.1172/jci.insight.178925
doi: 10.1172/jci.insight.178925
|
| [20] |
ZHOU W, WANG T, ZHU L J, et al. Associations of body mass index and remnant cholesterol with hyperuricemia in patients with hypertension[J]. BMC Endocr Disord,2025,25(1):73. doi:10.1186/s12902-025-01902-7
doi: 10.1186/s12902-025-01902-7
|
| [21] |
LIU B M, ZHAO L Y, YANG Q Q, et al. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fbrosis in patients with IgA nephropathy and membranous Nephropathy[J].Int Urol Nephrol, 2021,53(11): 2321-2332. doi:10.1007/s11255-021-02844-4
doi: 10.1007/s11255-021-02844-4
|
| [22] |
ZHANG K, TANG L, JIANG S S,et al. Is hyperuricemia an independent prognostic factor for IgA nephropathy: A systematic review and meta-analysis of observational cohort studies[J]. Ren Fail,2022,44(1):70-80. doi:10.1080/0886022x.2021.2019589
doi: 10.1080/0886022x.2021.2019589
|
| [23] |
TU M Y, HU S P, LOU Z Q. A high value of fibrinogen in immunoglobulin A nephropathy patients is associated with a worse renal tubular atrophy/interstitial fibrosis score[J]. J Clin Lab Anal,2022,36 (1):e24120. doi:10.1002/jcla.24120
doi: 10.1002/jcla.24120
|
| [24] |
MOHD R, MOHAMMAD K N E, ABDUL C R,et al. Long term outcome of immunoglo bulin A (IgA) nephropathy: A single center experience[J]. PloS one,2021,16 (4):249-265. doi:10.1371/journal.pone.0249592
doi: 10.1371/journal.pone.0249592
|
| [25] |
CHEN S X, CHEN J X, LI S M, et al. High-fat diet-induced renal proximal tubular inflammatory injury: Emerging risk factor of chronic kidney disease[J]. Front In Physiol,2021,12:786599. doi:10.3389/fphys.2021.786599
doi: 10.3389/fphys.2021.786599
|
| [26] |
DU X G, RUAN X Z. Lipid metabolism disorder and renal fibrosis[J]. Adv In Exp Med Biol,2019,1165:525-541. doi:10.1007/978-981-13-8871-2_26
doi: 10.1007/978-981-13-8871-2_26
|
| [27] |
FERRO C J, MARK P B, KANBAY M,et al. Lipid management in patients with chronic kidney disease[J]. Nat Rev Nephrol,2018,14(12):727-749. doi:10.1038/s41581-018-0072-9
doi: 10.1038/s41581-018-0072-9
|
| [28] |
WEN D M, TANG Y, TAN L,et al. Sex disparities in IgA nephropathy: A retrospective study in Chinese patients[J]. Int Urol Nephrol,2021,53(2):315-323. doi:10.1007/s11255-020-02631-7
doi: 10.1007/s11255-020-02631-7
|
| [29] |
CAO R, SU W, SHENG J, et al. Estrogen receptor β attenuates renal fibrosis by suppressing the transcriptional activity of Smad3[J]. Biochim Biophys Acta Mol Basis Dis,2023,1869(6):166755. doi:10.1016/j.bbadis.2023.166755
doi: 10.1016/j.bbadis.2023.166755
|
| [30] |
NASHAT A. Men's health disparities: Causes and interventions[J]. Nurs Forum,2022,57 (5):785-792. doi:10.1111/nuf.12764
doi: 10.1111/nuf.12764
|